Altmeyer P, Bergmeyer V, Wienand W
Dermatologische Klinik, Ruhr-Universität Bochum.
Hautarzt. 1997 Jan;48(1):12-20. doi: 10.1007/s001050050540.
Over 72,000 prescriptions from practicing dermatologists were reviewed to obtain an overview of current prescribing trends including both medical and economic aspects. One main point of concern was the quality of compounded prescriptions, which play an important role in dermatology, comprising 39.5% of the total and 47.8% of the topical prescriptions. Mixtures containing corticosteroids play a central role, being present in 45.2% of topical preparations, and comprising 35.9% of the standard preparations. While most mixtures were totally acceptable, some seemed questionable, either because of the number of active ingredients (as many as 7), the combinations (corticosteroid, antibiotics and antifungals) or the selected concentrations. The increased number of prescriptions and the use of compounding both appear fertile areas for cost-control measures.
对执业皮肤科医生开出的超过72000份处方进行了审查,以全面了解当前的处方趋势,包括医学和经济方面。一个主要关注点是复方制剂处方的质量,复方制剂在皮肤科中起着重要作用,占处方总数的39.5%,占外用处方的47.8%。含皮质类固醇的混合物起着核心作用,占外用制剂的45.2%,占标准制剂的35.9%。虽然大多数混合物完全可以接受,但有些似乎存在问题,原因要么是活性成分数量(多达7种)、成分组合(皮质类固醇、抗生素和抗真菌药),要么是所选浓度。处方数量的增加和复方制剂的使用似乎都是实施成本控制措施的有利领域。